← Back to catalogue
Research draft

cancer

vr.tr.cancer · XCT.STA

Let an agent give general, non-diagnostic information about cancer, point to screening, cancer services and support, and never give individual prognosis or treatment advice.

Thing Registry Cross-cutting context

Research draft, second pass

A second pass drafted this model: the structure a model of this thing needs, and what is known about it in the world. The line under this one says how the second half was obtained - researched against sources, or recalled without web access, in which case nothing here was read anywhere and every claim is a lead to verify. Unreviewed either way.

written by Claude from model knowledge without web access - no source was read, every claim is a lead to verify

Researched by: Claude

Purpose and description

Let an agent give general, non-diagnostic information about cancer, point to screening, cancer services and support, and never give individual prognosis or treatment advice.

A large group of diseases in which abnormal cells grow uncontrollably and can invade nearby tissues and spread to other parts of the body; types include carcinomas, sarcomas, leukaemias and lymphomas.

What it is for: A leading cause of illness and death addressed by prevention, screening, diagnosis and treatment.

It can be seek assessment for warning signs; join screening programmes; find reputable cancer information and support; discuss treatment with the care team.

Distinguishing features

Uncontrolled cell growth

Can invade and spread

Many types

Outcomes depend on type and stage

What it looks like

Not described; diagnosis is clinical and by pathology.

How it is recognised

Types by tissue: carcinoma, sarcoma, leukaemia, lymphoma

Staging systems

Benign tumours are not cancer

Related models

is a kind of - category

non-communicable disease

includes - type

carcinoma

is treated by - professionals

oncology team

is detected by - prevention

screening

In practice

Families and kinds

carcinomas

sarcomas

leukaemias

lymphomas and myelomas

brain and nervous system cancers

Identifiers

ICD-11 chapter 2 (neoplasms) cancers

Standards and regulation

National cancer screening programmes

WHO cancer guidance

European Code Against Cancer

Failure modes and hazards

Giving individual prognosis

Promoting unproven cures

Delaying assessment of warning signs

Where this came from

wikidata · CC0 1.0

Drafted structure

Bundle to layer to finding to question, as the second pass will find it: 4 bundles · 8 layers · 8 findings · 16 questions.

Concern Getting checked.

Assessment comes first.

Warning signs

See a doctor.

Signs

Warning signs.

  1. Should this symptom be checked by a doctor promptly? boundary
  2. Is there an urgent referral route? action

Screening

Programmes.

Screening

Screening.

  1. Which screening programmes is the person eligible for? provenance
  2. How are they accessed? action
Understanding General information.

Information stays general.

Types

Cancer types.

Types

Types.

  1. Which cancer type is being asked about? definition
  2. Which specific entry fits? action

Staging

General meaning.

Staging

Staging.

  1. What does staging mean in general terms? definition
  2. Who can explain an individual situation? boundary
Prevention Risk reduction.

Many cancers are preventable.

Risk factors

Evidence.

Risk

Risk factors.

  1. Which risk factors do reputable sources list? provenance
  2. Which vaccines help, such as HPV? provenance

Claims

Unproven cures.

Claims

Unproven claims.

  1. Is a claimed cure or prevention supported by evidence? provenance
  2. Who can advise? action
Support People affected.

Support matters.

Services

Helplines.

Services

Support services.

  1. Which cancer support services and helplines are available? action
  2. Is support available for carers and families? action

Trials

Research.

Trials

Clinical trials.

  1. How can someone find registered clinical trials? action
  2. Should they discuss it with their team? action

What the second pass must settle

  • Should cancer types be separate entries?
  • How should screening programmes be localised?
  • How should support services be linked?